Physician profile
Jihan A Grant
NPI 1871884072
$9,635.36
in general payments reported to CMS, 2019-2025
15 companies · $4,008 in 2025
The $4,008 reported for 2025 was more than what 85% of Pain Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $405).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $22.51 · 2021: $79.70 · 2022: $222 · 2023: $4,451 · 2024: $742 · 2025: $4,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,530 · Food and Beverage: $2,332 · Travel and Lodging: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,530.04 |
| Food and Beverage | $2,331.81 |
| Travel and Lodging | $338.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,057.31 | 2022-2025 | |
| Amneal Pharmaceuticals LLC | $2,511.29 | 2025 | Brekiya |
| Spr Therapeutics, INC | $467.55 | 2023-2024 | Sprint Pns System |
| Teva Pharmaceuticals USA, INC. | $366.98 | 2022-2025 | Ajovy |
| Impel Pharmaceuticals INC. | $332.43 | 2023 | Trudhesa |
| Lundbeck LLC | $192.61 | 2024-2025 | Vyepti |
| Nalu Medical, INC. | $148.65 | 2024 | Nalu Neurostimulation System |
| Axsome Therapeutics, INC. | $127.81 | 2025 | |
| Livanova USA, INC. | $126.03 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Lilly USA, LLC | $113.87 | 2019-2024 | Jardiance |
| Allergan, INC. | $102.21 | 2020-2021 | |
| Amgen INC. | $32.27 | 2023 | Aimovig |
| Arbor Pharmaceuticals, INC. | $20.28 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $19.62 | 2024 | Farxiga |
| Exact Sciences Corporation | $16.45 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jihan Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.